Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2021 Earnings Conference Call February 24, 2022 8:00 AM ET
Company Participants
Ian Karp – Senior Vice President-Investor Relations and Corporate Communications
John Leonard – Chief Executive Officer
Glenn Goddard – Chief Financial Officer
David Lebwohl – Chief Medical Officer
Laura Sepp-Lorenzino – Chief Scientific Officer
Conference Call Participants
Joon Lee – Truist
Maury Raycroft – Jefferies
Greco Song – SVB Leerink
Swapnil Malekar – Piper Sandler
Dae Gon Ha – Stifel
Luca Issi – RBC
Mike King – H.C. Wainwright
Ryan Deschner – Raymond James
Jay Olson – Oppenheimer
Yanan Zhu – Wells Fargo
Silvan Tuerkcan – JMP
Ry Forseth – Guggenheim
Operator
Good morning, and welcome to the Intellia Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call. My name is Andrew and I will be your conference operator today. Following formal remarks, we will open the call up for a question-and-answer session. This conference is being recorded at the company's request and will be available on the company's website following the end of the call. As a reminder, all participants are currently in listen-only mode. [Operator Instructions]
I will now turn the conference over to Ian Karp, Senior Vice President of Investor Relations and Corporate Communications at Intellia. Please proceed.
Ian Karp
Thank you, operator. Good morning, everyone. Welcome to Intellia Therapeutics fourth quarter and full year 2021 earnings call. Earlier this morning, Intellia issued a press release outlining the company's progress this quarter as well as topics for discussion on today's call. This release can be found on the Investors & Media section of Intellia's website at intelliatx.com. This call is being broadcast live, and a replay will be archived on the company's website.
At this time, I would like to take a minute to remind listeners that during the
- Read more current NTLA analysis and news
- View all earnings call transcripts